Literature DB >> 2346320

Early diagnosis of cutaneous malignant melanoma at Lawrence Livermore National Laboratory.

J S Schneider1, D H Moore, R W Sagebiel.   

Abstract

The Lawrence Livermore (Calif) National Laboratory (LLNL) has observed a threefold increase in incidence of cutaneous malignant melanoma (CMM) since 1972. A consultant pathologist reviewed 49 of 50 cases of CMM diagnosed from 1969 to 1984 and reclassified 4 cases; this did not significantly affect the elevated rate. A comparison of the thicknesses of CMM at LLNL from 1976 to 1984 with those from a nearby community histopathology laboratory showed that 74% of the LLNL cases were Clark level I or II, compared with 40% of the comparison laboratory cases. A matched-pair comparison controlling for age, sex, and year of diagnosis showed the LLNL cases were thinner in 58% of the pairs. The median thickness of CMMs at LLNL decreased faster than those from the comparison laboratory.

Entities:  

Mesh:

Year:  1990        PMID: 2346320

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

1.  Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.

Authors:  M A Weinstock; J P Lott; Q Wang; L J Titus; T Onega; H D Nelson; L Pearson; M Piepkorn; R L Barnhill; J G Elmore; A N A Tosteson
Journal:  Br J Dermatol       Date:  2017-03-01       Impact factor: 9.302

2.  Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties.

Authors:  G Gong; A S Whittemore; D West; D H Moore
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.